Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acecainide
2. Acecainide Monohydrochloride
3. Acetylprocainamide
4. Hydrochloride, Acecainide
5. Monohydrochloride, Acecainide
6. N Acetylprocainamide
7. N-acetylprocainamide
1. 34118-92-8
2. N-acetylprocainamide Hydrochloride
3. Acecainide Hcl
4. Napa
5. Asl 601
6. Asl-601
7. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hydrochloride
8. Acecainide Hydrochloride [usan]
9. Nsc-759312
10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide Monohydrochloride
11. 34118-92-8 (hcl)
12. Mls000863278
13. Asl601;acecainide Hydrochloride
14. B9k738kx14
15. N-acetylprocainamide (hydrochloride)
16. Ncgc00093534-02
17. Dsstox_cid_25748
18. Dsstox_rid_81092
19. Dsstox_gsid_45748
20. Acecainide Hydrochloride (usan)
21. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-, Monohydrochloride
22. Smr000059132
23. Cas-34118-92-8
24. Unii-b9k738kx14
25. Sr-01000000030
26. Einecs 251-831-2
27. Opera_id_64
28. Asl 601(acecainide)
29. Mls000028843
30. Mls001148141
31. Schembl122991
32. Spectrum2300154
33. Chembl1256805
34. Dtxsid1045748
35. Pharmakon1600-02300154
36. Bcp20733
37. Tox21_111206
38. Tox21_500009
39. Acecainide Hydrochloride [mi]
40. Nsc759312
41. Akos015888341
42. Tox21_111206_1
43. Ccg-213649
44. Lp00009
45. Nsc 759312
46. Acecainide Hydrochloride [mart.]
47. N-acetylprocainamide Hydrochloride, 99%
48. Ncgc00015072-10
49. Ncgc00093534-01
50. Ncgc00093534-03
51. Ncgc00260694-01
52. As-75674
53. Db-048569
54. Eu-0100009
55. Ft-0639157
56. A 5909
57. A20512
58. D02746
59. N16908
60. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hcl
61. J-019456
62. Sr-01000000030-2
63. Acedainide; N-acetylnovocainamide Hydrochloride; Napa
64. Q27274550
65. 4-acetamido-n-(2-(diethylamino)ethyl)benzamidehydrochloride
66. N-acetylprocainamide Hydrochloride, >=99% (hplc), Powder
67. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide;hydrochloride
Molecular Weight | 313.82 g/mol |
---|---|
Molecular Formula | C15H24ClN3O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 7 |
Exact Mass | 313.1557047 g/mol |
Monoisotopic Mass | 313.1557047 g/mol |
Topological Polar Surface Area | 61.4 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 308 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
ABOUT THIS PAGE
A Acecainide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acecainide, including repackagers and relabelers. The FDA regulates Acecainide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acecainide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acecainide supplier is an individual or a company that provides Acecainide active pharmaceutical ingredient (API) or Acecainide finished formulations upon request. The Acecainide suppliers may include Acecainide API manufacturers, exporters, distributors and traders.
click here to find a list of Acecainide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acecainide DMF (Drug Master File) is a document detailing the whole manufacturing process of Acecainide active pharmaceutical ingredient (API) in detail. Different forms of Acecainide DMFs exist exist since differing nations have different regulations, such as Acecainide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acecainide DMF submitted to regulatory agencies in the US is known as a USDMF. Acecainide USDMF includes data on Acecainide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acecainide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acecainide suppliers with USDMF on PharmaCompass.
Acecainide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acecainide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acecainide GMP manufacturer or Acecainide GMP API supplier for your needs.
A Acecainide CoA (Certificate of Analysis) is a formal document that attests to Acecainide's compliance with Acecainide specifications and serves as a tool for batch-level quality control.
Acecainide CoA mostly includes findings from lab analyses of a specific batch. For each Acecainide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acecainide may be tested according to a variety of international standards, such as European Pharmacopoeia (Acecainide EP), Acecainide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acecainide USP).
LOOKING FOR A SUPPLIER?